Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2

  • M. J. Desmond
    Departments of 1Nephrology and
  • D. Lee
    Departments of 1Nephrology and
  • S. A. Fraser
    The Institute for Breathing and Sleep,
  • M. Katerelos
    The Institute for Breathing and Sleep,
  • K. Gleich
    The Institute for Breathing and Sleep,
  • P. Martinello
    Anatomical Pathology,
  • Y. Q. Li
    The Institute for Breathing and Sleep,
  • M. C. Thomas
    Danielle Alberti Memorial Centre for Diabetic Complications, Baker IDI Heart and Diabetes Institute, Victoria;
  • R. Michelucci
    Neurology Unit, Department of Neurosciences, Bellaria Hospital, University of Bologna, Bologna, Italy;
  • A. J. Cole
    Epilepsy Service, Massachusetts General Hospital, Boston, Massachusetts;
  • P. Saftig
    Institut für Biochemie, Christian-Albrechts-Universität zu Kiel, Kiel, Germany; and
  • M. Schwake
    Institut für Biochemie, Christian-Albrechts-Universität zu Kiel, Kiel, Germany; and
  • D. Stapleton
    Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia
  • S. F. Berkovic
    Epilepsy Research Centre,
  • D. A. Power
    Departments of 1Nephrology and

この論文をさがす

説明

<jats:p> Deficiency of the intrinsic lysosomal protein human scavenger receptor class B, member 2 (SCARB2; Limp-2 in mice) causes collapsing focal and segmental glomerular sclerosis (FSGS) and myoclonic epilepsy in humans, but patients with no apparent kidney damage have recently been described. We now demonstrate that these patients can develop tubular proteinuria. To determine the mechanism, mice deficient in Limp-2, the murine homolog of SCARB2, were studied. Most low-molecular-weight proteins filtered by the glomerulus are removed in the proximal convoluted tubule (PCT) by megalin/cubilin-dependent receptor-mediated endocytosis. Expression of megalin and cubilin was unchanged in Limp-2<jats:sup>−/−</jats:sup> mice, however, and the initial uptake of injected Alexa Fluor 555-conjugated bovine serum albumin (Alexa-BSA) was similar to wild-type mice, indicating that megalin/cubilin-dependent, receptor-mediated endocytosis was unaffected. There was a defect in proteolysis of reabsorbed proteins in the Limp-2<jats:sup>−/−</jats:sup> mice, demonstrated by the persistence of Alexa-BSA in the PCT compared with controls. This was associated with the failure of the lysosomal protease cathepsin B to colocalize with Alexa-BSA and endogenous retinol-binding protein in kidneys from Limp-2<jats:sup>−/−</jats:sup> mice. The data suggest that tubular proteinuria in Limp-2<jats:sup>−/−</jats:sup> mice is due to failure of endosomes containing reabsorbed proteins to fuse with lysosomes in the proximal tubule of the kidney. Failure of proteolysis is a novel mechanism for tubular proteinuria. </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ